MiR-21 overexpression is associated with acquired resistance of EGFR-TKI in non-small cell lung cancer

Imran Bhatti, Andrew Lee, Victoria James, Richard I. Hall, Jonathan N. Lund, Cristina Tufarelli, Dileep N. Lobo, Michael Larvin, Knockdown of microRNA-21 Inhibits Proliferation and Increases Cell Death by Targeting Programmed Cell Death 4 (PDCD4) in Pancreatic Ductal Adenocarcinoma Journal of Gastrointestinal Surgery. ,vol. 15, pp. 199- 208 ,(2011) , 10.1007/S11605-010-1381-X

Simona Rossi, Masayoshi Shimizu, Elisa Barbarotto, Milena S. Nicoloso, Federica Dimitri, Deepa Sampath, Muller Fabbri, Susan Lerner, Lynn L. Barron, Laura Z. Rassenti, Li Jiang, Lianchun Xiao, Jianhua Hu, Paola Secchiero, Giorgio Zauli, Stefano Volinia, Massimo Negrini, William Wierda, Thomas J. Kipps, William Plunkett, Kevin R. Coombes, Lynne V. Abruzzo, Michael J. Keating, George A. Calin, MicroRNA fingerprinting of CLL patients with chromosome 17p deletion identify a miR-21 score that stratifies early survival Blood. ,vol. 116, pp. 945- 952 ,(2010) , 10.1182/BLOOD-2010-01-263889

Hsin-Sheng Yang, Jennifer L Knies, Cristi Stark, Nancy H Colburn, Pdcd4 suppresses tumor phenotype in JB6 cells by inhibiting AP-1 transactivation Oncogene. ,vol. 22, pp. 3712- 3720 ,(2003) , 10.1038/SJ.ONC.1206433

Yi-Long Wu, Joo-Hang Kim, Keunchil Park, Adel Zaatar, Gaëlle Klingelschmitt, Christina Ng, Efficacy and safety of maintenance erlotinib in Asian patients with advanced non-small-cell lung cancer: A subanalysis of the phase III, randomized SATURN study Lung Cancer. ,vol. 77, pp. 339- 345 ,(2012) , 10.1016/J.LUNGCAN.2012.03.012

S. Duygu Selcuklu, Mark T.A. Donoghue, Charles Spillane, miR-21 as a key regulator of oncogenic processes Biochemical Society Transactions. ,vol. 37, pp. 918- 925 ,(2009) , 10.1042/BST0370918

Wen Gao, Yue Yu, Hailong Cao, Hua Shen, Xiaodong Li, Shiyang Pan, Yongqian Shu, Deregulated expression of miR-21, miR-143 and miR-181a in non small cell lung cancer is related to clinicopathologic characteristics or patient prognosis Biomedicine & Pharmacotherapy. ,vol. 64, pp. 399- 408 ,(2010) , 10.1016/J.BIOPHA.2010.01.018

Zhao-Xia Wang, Bin-Bin Lu, He Wang, Zhi-Xiang Cheng, Yong-Mei Yin, MicroRNA-21 modulates chemosensitivity of breast cancer cells to doxorubicin by targeting PTEN. Archives of Medical Research. ,vol. 42, pp. 281- 290 ,(2011) , 10.1016/J.ARCMED.2011.06.008

Guo-hai Shi, Ding-wei Ye, Xu-dong Yao, Shi-ling Zhang, Bo Dai, Hai-liang Zhang, Yi-jun Shen, Yao Zhu, Yi-ping Zhu, Wen-jun Xiao, Chun-guang Ma, Involvement of microRNA-21 in mediating chemo-resistance to docetaxel in androgen-independent prostate cancer PC3 cells. Acta Pharmacologica Sinica. ,vol. 31, pp. 867- 873 ,(2010) , 10.1038/APS.2010.48

Tudor Ciuleanu, Lilia Stelmakh, Saulius Cicenas, Skaidrius Miliauskas, Alexandru Calin Grigorescu, Carina Hillenbach, Hrefna Kristin Johannsdottir, Barbara Klughammer, Emilio Esteban Gonzalez, Efficacy and safety of erlotinib versus chemotherapy in second-line treatment of patients with advanced, non-small-cell lung cancer with poor prognosis (TITAN): a randomised multicentre, open-label, phase 3 study Lancet Oncology. ,vol. 13, pp. 300- 308 ,(2012) , 10.1016/S1470-2045(11)70385-0

Julius Brennecke, David R. Hipfner, Alexander Stark, Robert B. Russell, Stephen M. Cohen, bantam Encodes a Developmentally Regulated microRNA that Controls Cell Proliferation and Regulates the Proapoptotic Gene hid in Drosophila Cell. ,vol. 113, pp. 25- 36 ,(2003) , 10.1016/S0092-8674(03)00231-9